This company is no longer active
The company may no longer be operating, as it may be out of business. Find out why through their latest events.
Brookline Capital Acquisition Management
Management criteria checks 1/4
Key information
Sam Wertheimer
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 2.2yrs |
| CEO ownership | n/a |
| Management average tenure | 2.2yrs |
| Board average tenure | 1.4yrs |
Recent management updates
Recent updates
CEO
Sam Wertheimer
2.2yrs
Tenure
Dr. Samuel P. Wertheimer, also known as Sam, has served as Executive Vice President of Poliwogg Regenerative Medicine Fund, Inc. and is currently Chief Investment Officer and a Managing Director of Poliwog...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 2.2yrs | no data | no data | |
| President & Director | 2.2yrs | no data | no data | |
| Chief Financial Officer | 2.2yrs | no data | no data |
2.2yrs
Average Tenure
Experienced Management: BCAC's management team is considered experienced (2.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 2.2yrs | no data | no data | |
| President & Director | 1.4yrs | no data | no data | |
| Independent Director | 1.4yrs | no data | no data | |
| Independent Director | 1.4yrs | no data | no data | |
| Independent Director | 1.4yrs | no data | no data |
1.4yrs
Average Tenure
64yo
Average Age
Experienced Board: BCAC's board of directors are not considered experienced ( 1.4 years average tenure), which suggests a new board.